13 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Ocugen, Inc. OCGN shares rose 20.3% to $1.54 during Wednesday's pre-market session. The market cap stands at $4.4 million.
• Advaxis, Inc. ADXS shares increased by 6.0% to $0.41. The market cap seems to be at $6.1 million.
• SmileDirectClub, Inc. SDC shares moved upwards by 4.4% to $11.83. The market cap seems to be at $6.0 billion. According to the most recent rating by William Blair, on October 07, the current rating is at Outperform.
• Cancer Genetics, Inc. CGIX stock increased by 3.0% to $0.17. The market value of their outstanding shares is at $6.1 million.
• MorphoSys, Inc. MOR shares increased by 2.1% to $27.20. The market value of their outstanding shares is at $3.6 billion.
• Teva Pharmaceutical Indus, Inc. TEVA stock surged 1.4% to $6.62. The market cap seems to be at $7.6 billion. The most recent rating by Wells Fargo, on September 30, is at Market Perform, with a price target of $8.00.
• Fresenius Medical Care, Inc. FMS shares increased by 1.3% to $32.52. The market cap stands at $20.3 billion. According to the most recent rating by BTIG, on August 01, the current rating is at Neutral.
• AstraZeneca, Inc. AZN shares surged 1.0% to $43.47. The market cap seems to be at $117.0 billion.
• Royal Philips, Inc. PHG shares increased by 1.0% to $45.40. The market cap seems to be at $42.0 billion.

Losers

• DBV Technologies, Inc. DBVT stock plummeted 6.0% to $6.91 during Wednesday's pre-market session. The market cap stands at $620.4 million.
• Johnson & Johnson, Inc. JNJ shares fell 2.1% to $129.10. The market value of their outstanding shares is at $347.1 billion. The most recent rating by Morgan Stanley, on August 27, is at Equal-Weight, with a price target of $145.00.
• Neurotrope, Inc. NTRP stock fell 1.5% to $0.67. The market cap seems to be at $10.2 million. According to the most recent rating by Janney Capital, on September 11, the current rating is at Neutral.
• Qiagen, Inc. QGEN shares fell 1.4% to $25.06. The market value of their outstanding shares is at $7.4 billion. According to the most recent rating by Kepler Cheuvreux, on October 09, the current rating is at Reduce.